About Nemera
Nemera is a company based in La Verpilliere (France) founded in 2014 was acquired by Astorg Partners in October 2018. Nemera has completed 2 acquisitions, including Copernicus and Insight Innovation Labs. Nemera offers products and services including Dermal Devices, Ear Devices, Nose Devices, Throat Devices, and Inhalation Devices. Nemera operates in a competitive market with competitors including Ensysce, Arecor, Oxular, EryDel and PharmaJet, among others.
- Headquarter La Verpilliere, France
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nemera Buffalo Grove Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
LGT Capital Partners
& 3 more
-
Employee Count
Not available
-
Investments & Acquisitions
Copernicus
& 1 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nemera
Nemera offers a comprehensive portfolio of products and services, including Dermal Devices, Ear Devices, Nose Devices, Throat Devices, and Inhalation Devices.
Devices for dermal drug administration and treatment efficacy.
Tools for ear-related drug delivery solutions.
Devices designed for nasal drug administration.
Products for throat-based drug delivery systems.
Equipment for inhalation-based treatment delivery.
Devices focused on intimate health drug applications.
Tools for eye-related drug delivery.
Systems for oral drug delivery mechanisms.
Devices for injectable drug administration.
People of Nemera
Unlock access to complete
Software Development Team
38 people
Leadership Team
14 people
Human Resources and Administration
12 people
Sales and Marketing
10 people
Finance and Accounting
6 people
Product Management Team
6 people
Senior Team
5 people
Operations Team
5 people
Unlock access to complete
Funding Insights of Nemera
Investors in Nemera
Nemera has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include LGT Capital Partners, European Union and Astorg.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Principal investments in alternative strategies are made alongside clients.
|
Locked | Locked | Locked | |
|
Astorg is engaged in private equity investment management.
|
Locked | Locked | Locked | |
|
Montagu Private Equity is engaged in mid-market business investments.
|
Locked | Locked | Locked |
Investor details for Nemera
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nemera
Nemera has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Copernicus and Insight Innovation Labs.
Investment portfolio details for Nemera
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Research and innovation platform that enables the development technologies in the healthcare sector
|
Locked | Locked | 1988 | Locked | |
|
Earth observation data and services are provided globally by Copernicus.
|
Locked | Locked | 0 | Locked |
Complete acquisition details for Nemera
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Nemera
Detailed financials for Nemera
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nemera Comparisons
Peer comparison for Nemera
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nemera
Nemera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ensysce, Arecor, Oxular, EryDel and PharmaJet, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug delivery solutions via single-walled carbon nanotubes are offered.
|
|
| Locked | Locked | Locked |
Developer of proteins, vaccines based on proprietary stabilization technologies for drug delivery
|
|
| Locked | Locked | Locked |
Drug delivery platforms and therapeutics for ophthalmology are developed.
|
|
| Locked | Locked | Locked |
Erythrocyte encapsulation systems for drug delivery are developed.
|
|
| Locked | Locked | Locked |
Provider of needle-free injection technology
|
|
| Locked | Locked | Locked |
Provider of a proprietary platform for gene therapy
|
Detailed competitors of Nemera
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nemera
Complete news archive for Nemera
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nemera
Nemera was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Nemera is headquartered in La Verpilliere, France. It is registered at La Verpilliere, Isere, France.
Nemera was established in 2014 through a management buyout by Montagu Private Equity, acquiring units from Rexam PLC. Operations focus on producing plastic drug delivery devices across sectors including ophthalmic, earnosethroat, inhalation, dermaltransdermal, and parenteral applications. Products encompass multidose eyedroppers, sprays, pumps, auto-injectors, and safety devices, with brands such as Advancia, Inhalia, SafenSound, and Novelia. The company is based in La Verpillière, France, serving global pharmaceutical needs.
Nemera's top competitors include Oxular, PharmaJet and Splice Bio.
Nemera offers Dermal Devices, Ear Devices, Nose Devices, Throat Devices, and 5 more products and services.
Nemera has made 2 acquisitions, including Copernicus, and Insight Innovation Labs.
Nemera has 4 investors. Key investors include LGT Capital Partners, European Union, Astorg, and Montagu Private Equity.